Ananda Scientific, is a research driven Biotech Company developing prescription medicines for neuropsychiatric health. We have six well-controlled Phase II (double blind placebo controlled) clinical trials underway with high quality academic institutions. Our lead indication is PTSD, and we are also studying Opioid Use Disorder, Social Anxiety Disorder and Smoking Cessation. We have established GxP compliant drug development and manufacturing infrastructure and have an experienced team in place capable or moving multiple indications forward for FDA approval. We are currently looking to raise capital to accelerate our PTSD clinical development program into phase III.